Cargando…

Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers

INTRODUCTION: Cytokine-release syndrome (CRS) in COVID-19 patients can cause multiorgan failure and higher mortality. We used a structured protocol based on clinical, biochemical, and interleukin 6 (IL-6) criteria for the identification of the subset of patients with CRS and analyzed the use of toci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasa, Prashant, Singh, Aanchal, Upadhyay, Surjya, Bagadia, Sukhant, Polumuru, Srinivasa, Shrivastava, Pavan K, Sankar, Rakesh, Vijayan, Lexy, Soliman, Mohamed A, Ali, Alaeldin, Patidar, Saroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584850/ https://www.ncbi.nlm.nih.gov/pubmed/33132558 http://dx.doi.org/10.5005/jp-journals-10071-23566

Ejemplares similares

Percutaneous Tracheostomy in COVID-19 Patients: A Four-step Safe Protocol
por: Nasa, Prashant, et al.
Publicado: (2020)

Thrombotic Microangiopathy Causing Acute Kidney Injury in a COVID-19 Patient
por: Kulkarni, Amitabh, et al.
Publicado: (2021)

Euglycemic diabetic ketoacidosis: A missed diagnosis
por: Nasa, Prashant, et al.
Publicado: (2021)

Cardioembolic Stroke with Peripartum Cardiomyopathy: An Unusual Presentation
por: Nasa, Prashant, et al.
Publicado: (2021)

Psychological distress among survivors of moderate-to-critical COVID-19 illness: A multicentric prospective cross-sectional study
por: Imran, Javaria, et al.
Publicado: (2021)

Demographic and risk characteristics of healthcare workers infected with SARS-CoV-2 from two tertiary care hospitals in the United Arab Emirates
por: Nasa, Prashant, et al.
Publicado: (2023)

The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
por: de Cáceres, Carmen, et al.
Publicado: (2020)

Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
por: Hassoun, Ali, et al.
Publicado: (2020)

Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
por: Sarhan, Neven Mohamed, et al.
Publicado: (2023)

Effectiveness of Tocilizumab in a COVID-19 Patient with Cytokine Release Syndrome
por: Uslu, Sadettin
Publicado: (2020)

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
por: van Kraaij, Tom DA, et al.
Publicado: (2020)

Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date
por: Si, Stephanie, et al.
Publicado: (2020)

Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome()
por: Velasco Puyó, Pablo, et al.
Publicado: (2020)

Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report
por: Radbel, Jared, et al.
Publicado: (2020)

Therapeutic Effect of Tocilizumab on Inhibiting Cytokine Release Syndrome in Severe Coronavirus Disease 2019 Patients
por: Xu, Lengnan, et al.
Publicado: (2022)

Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
por: Liu, Danfei, et al.
Publicado: (2020)

Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes
por: Price, Christina C., et al.
Publicado: (2020)

Tocilizumab and Cytokine Release Syndrome in COVID-19 Pneumonia: Experience From a Single Center in Pakistan
por: Hassan, Muhammad, et al.
Publicado: (2021)

Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India
por: Dravid, Ameet, et al.
Publicado: (2021)

Subcutaneous tocilizumab treatment in patients with severe COVID-19–related cytokine release syndrome: An observational cohort study
por: Mastroianni, Antonio, et al.
Publicado: (2020)

Case Study: A Patient with Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab
por: Schleicher, Gunter K, et al.
Publicado: (2020)

Transient Myelin Oligodendrocyte Glycoprotein Antibody-positive Acute Disseminated Encephalomyelitis Following Influenza A Infection: A Rare Case
por: Nasa, Prashant, et al.
Publicado: (2021)

Can tocilizumab calm the cytokine storm of COVID-19?
por: Schulert, Grant S
Publicado: (2020)

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
por: Zhang, Chi, et al.
Publicado: (2020)

Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome
por: Ali, Sabahat, et al.
Publicado: (2021)

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
por: Le, Robert Q., et al.
Publicado: (2018)

Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results
por: Sánchez-Martínez, Francesca, et al.
Publicado: (2021)

Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies
por: Kaminski, Monica A., et al.
Publicado: (2020)

Spinal epidural haematoma following removal of epidural catheter after an elective intra-abdominal surgery
por: Mahapatra, Sudeep, et al.
Publicado: (2016)

Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
por: Gautier-Vargas, Gabriela, et al.
Publicado: (2020)

Interleukin-6 Antagonist Tocilizumab to Treat Critically Ill Coronavirus Disease 2019 Patients With Cytokine Release Syndrome: A Case Series
por: Yang, Stephen Su, et al.
Publicado: (2021)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy
por: Lebedeva, Anna, et al.
Publicado: (2022)

Unusual bulging (ballooning) of the laryngeal mask airway cuff causing secondary loss of airway
por: Upadhyay, Surjya Prasad, et al.
Publicado: (2012)

Perioperative Automated Noninvasive Blood Pressure- (NIBP-) Related Peripheral Nerve Injuries: An Anesthetist's Dilemma—A Case Report and Review of the Literature
por: Elmatite, Waleed, et al.
Publicado: (2020)

“Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience”, a retrospective study-original article
por: Chachar, Aijaz Zeeshan Khan, et al.
Publicado: (2021)

Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study
por: Chober, Daniel, et al.
Publicado: (2022)

Bioprospecting and biotechnological applications of fungal laccase
por: Upadhyay, Pooja, et al.
Publicado: (2016)

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
por: Saha, Abinit, et al.
Publicado: (2020)

Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
por: Antinori, Spinello, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tsjn0qie8hafiq8dv76d050pfg